Zhen-guang B. Wang
225 Changhai Road
Shanghai, 200438, China
Shanghai, 200438, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.
Journal: Frontiers in immunology
Published: April 01, 2023
Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell-mediated antitumor activity.
Journal: Frontiers in immunology
Published: November 09, 2022
Corrigendum to "miR-515-5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway" [Surg Oncol. (2020 Sep) 34 113-120].
Journal: Surgical oncology
Published: August 14, 2022
Low CPEB1 levels may predict the benefit of 5-fluorouracil treatment in patients with colon or stomach adenocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: June 02, 2022
Antidiabetic treatment improves prognosis after radical resection in hepatocellular carcinoma patients with diabetes mellitus: a retrospective cohort study from 2000 to 2013.
Journal: Journal of gastrointestinal oncology
Published: April 26, 2022
N6-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis.
Journal: International journal of biological sciences
Published: April 03, 2022
Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell-Mediated Antitumor Activity.
Journal: Frontiers in immunology
Published: December 29, 2021
Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC).
Journal: Expert opinion on therapeutic targets
Published: February 29, 2020
High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 06, 2019
MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF expression.
Journal: Scientific reports
Published: April 08, 2019
Tropomodulin 3 modulates EGFR-PI3K-AKT signaling to drive hepatocellular carcinoma metastasis.
Journal: Molecular carcinogenesis
Published: March 18, 2019
miR-515-5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway.
Journal: Surgical oncology
Published: March 04, 2019
Last Updated: 09/26/2026